Found: 16
Select item for more details and to access through your institution.
Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study.
- Published in:
- EP: Europace, 2015, v. 17, n. 8, p. 1215, doi. 10.1093/europace/euv119
- By:
- Publication type:
- Article
Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark.
- Published in:
- Scientific Reports, 2016, p. 31477, doi. 10.1038/srep31477
- By:
- Publication type:
- Article
Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141377
- By:
- Publication type:
- Article
Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study.
- Published in:
- European Heart Journal, 2019, v. 40, n. 46, p. 3782, doi. 10.1093/eurheartj/ehz155
- By:
- Publication type:
- Article
Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study.
- Published in:
- Thrombosis Journal, 2019, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12959-019-0211-y
- By:
- Publication type:
- Article
On the estimation of average treatment effects with right‐censored time to event outcome and competing risks.
- Published in:
- Biometrical Journal, 2020, v. 62, n. 3, p. 751, doi. 10.1002/bimj.201800298
- By:
- Publication type:
- Article
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients.
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 2, p. 1, doi. 10.1161/JAHA.116.004517
- By:
- Publication type:
- Article
Outcomes Associated With Familial Versus Nonfamilial Atrial Fibrillation: A Matched Nationwide Cohort Study.
- Published in:
- Journal of the American Heart Association, 2016, v. 5, n. 11, p. 1, doi. 10.1161/JAHA.116.003836
- By:
- Publication type:
- Article
Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation.
- Published in:
- PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161768
- By:
- Publication type:
- Article
Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study.
- Published in:
- European Heart Journal, 2018, v. 39, n. 19, p. 1698, doi. 10.1093/eurheartj/ehx598
- By:
- Publication type:
- Article
Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark.
- Published in:
- European Heart Journal, 2017, v. 38, n. 12, p. 899, doi. 10.1093/eurheartj/ehw658
- By:
- Publication type:
- Article
Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.
- Published in:
- European Heart Journal, 2017, v. 38, n. 12, p. 907, doi. 10.1093/eurheartj/ehw496
- By:
- Publication type:
- Article